Influenza Vaccines: Successes and Continuing Challenges.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
30 09 2021
Historique:
entrez: 30 9 2021
pubmed: 1 10 2021
medline: 11 3 2022
Statut: ppublish

Résumé

Influenza vaccines have been available for over 80 years. They have contributed to significant reductions in influenza morbidity and mortality. However, there have been limitations in their effectiveness, in part due to the continuous antigenic evolution of seasonal influenza viruses, but also due to the predominant use of embryonated chicken eggs for their production. The latter furthermore limits their worldwide production timelines and scale. Therefore today, alternative approaches for their design and production are increasingly pursued, with already licensed quadrivalent seasonal influenza vaccines produced in cell cultures, including based on a baculovirus expression system. Next-generation influenza vaccines aim at inducing broader and longer-lasting immune responses to overcome seasonal influenza virus antigenic drift and to timely address the emergence of a new pandemic influenza virus. Tailored approaches target mechanisms to improve vaccine-induced immune responses in individuals with a weakened immune system, in particular older adults.

Identifiants

pubmed: 34590139
pii: 6378092
doi: 10.1093/infdis/jiab269
pmc: PMC8482026
doi:

Substances chimiques

Influenza Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

S405-S419

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America.

Références

Front Immunol. 2019 Apr 12;10:809
pubmed: 31031778
Curr Opin Virol. 2019 Feb;34:1-9
pubmed: 30497050
N Engl J Med. 2014 Aug 14;371(7):635-45
pubmed: 25119609
Cochrane Database Syst Rev. 2010 Feb 17;(2):CD004876
pubmed: 20166072
J Virol Methods. 2014 Dec 15;210:7-14
pubmed: 25233882
Psychol Bull. 2004 Jul;130(4):601-30
pubmed: 15250815
Nature. 2006 Dec 14;444(7121):860-7
pubmed: 17167474
Vaccines (Basel). 2018 May 21;6(2):
pubmed: 29883414
N Engl J Med. 2017 Jun 22;376(25):2427-2436
pubmed: 28636855
Adv Exp Med Biol. 2011;719:59-66
pubmed: 22125035
J Exp Med. 1931 Jul 31;54(3):373-85
pubmed: 19869924
J Virol. 2011 Nov;85(22):12057-61
pubmed: 21917970
J Virol. 2015 Jul;89(14):7224-34
pubmed: 25948745
Vaccine. 2017 Jan 23;35(4):513-520
pubmed: 28024956
Expert Rev Vaccines. 2017 Feb;16(2):123-136
pubmed: 27653543
Nature. 1977 May 26;267(5609):354-6
pubmed: 194164
Am J Respir Crit Care Med. 2015 Jun 15;191(12):1422-31
pubmed: 25844934
Vaccine. 1998 May-Jun;16(9-10):1009-15
pubmed: 9682352
Nat Rev Immunol. 2019 Sep;19(9):573-583
pubmed: 31186548
Viruses. 2014 Jul 17;6(7):2735-61
pubmed: 25036462
J Immunol. 2004 May 1;172(9):5598-605
pubmed: 15100303
J Gen Virol. 2013 Mar;94(Pt 3):583-592
pubmed: 23152369
Curr Opin Immunol. 2018 Aug;53:88-95
pubmed: 29719276
Int J Clin Pract. 2018 Oct;72(10):e13249
pubmed: 30216647
Nat Med. 2012 Jan 29;18(2):274-80
pubmed: 22286307
J Virol Methods. 2015 Jun 1;217:55-63
pubmed: 25712563
Viruses. 2019 Feb 20;11(2):
pubmed: 30791550
Science. 2000 May 12;288(5468):1051-3
pubmed: 10807575
Int J Obes (Lond). 2012 Aug;36(8):1072-7
pubmed: 22024641
Vaccine. 2008 Sep 12;26 Suppl 4:D31-4
pubmed: 19230156
J Virol. 1989 Mar;63(3):1239-46
pubmed: 2915381
Cell Host Microbe. 2019 Jun 12;25(6):773-775
pubmed: 31194938
J Infect Dis. 1979 Dec;140(6):844-50
pubmed: 396336
Lancet Respir Med. 2017 Sep;5(9):738-746
pubmed: 28736045
Science. 2012 Sep 14;337(6100):1343-8
pubmed: 22878502
J Virol. 2010 Jul;84(13):6527-35
pubmed: 20410263
Vaccine. 2009 Oct 23;27(45):6296-9
pubmed: 19840663
Vaccine. 2009 Aug 6;27(36):4983-9
pubmed: 19538996
Viruses. 2012 Sep;4(9):1438-76
pubmed: 23170167
Expert Rev Vaccines. 2020 Jan;19(1):43-55
pubmed: 31903816
J Immunol. 2011 Apr 1;186(7):4331-9
pubmed: 21357542
Vaccine. 2017 Jul 24;35(33):4167-4176
pubmed: 28655451
J Infect Dis. 2019 Apr 8;219(Suppl_1):S68-S74
pubmed: 30715367
Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004876
pubmed: 16856068
PLoS One. 2011;6(10):e26335
pubmed: 22039464
Hum Vaccin Immunother. 2018 Mar 4;14(3):571-578
pubmed: 28933664
PLoS One. 2009 Nov 12;4(11):e7790
pubmed: 19915662
Clin Vaccine Immunol. 2013 Aug;20(8):1333-7
pubmed: 23761662
Science. 2004 Jul 16;305(5682):371-6
pubmed: 15218094
Lancet. 2018 Mar 31;391(10127):1285-1300
pubmed: 29248255
J Infect Dis. 2015 Oct 15;212(8):1191-9
pubmed: 25858957
Immunotherapy. 2011 Feb;3(2):213-27
pubmed: 21322760
J Infect Dis. 2004 Feb 1;189(3):459-61
pubmed: 14745703
Hum Vaccin Immunother. 2015;11(3):553-63
pubmed: 25714138
Cancer Cell Microenviron. 2015;2(1):
pubmed: 26005708
Vaccine. 2002 Jan 31;20(9-10):1340-53
pubmed: 11818152
Expert Rev Vaccines. 2019 Jul;18(7):737-750
pubmed: 31265333
Vaccine. 2017 May 15;35(21):2775-2780
pubmed: 28431815
J Exp Med. 1985 Jan 1;161(1):198-209
pubmed: 2981953
Vaccine. 1993;11(10):1037-9
pubmed: 8212824
J Virol. 1968 Apr;2(4):281-8
pubmed: 4911843
Lancet Infect Dis. 2008 Aug;8(8):460-1; author reply 463-5
pubmed: 18652989
J Virol. 2010 Oct;84(19):10366-74
pubmed: 20686020
J Gen Virol. 2011 Oct;92(Pt 10):2339-2349
pubmed: 21653752
Vaccine. 2019 May 31;37(25):3326-3334
pubmed: 31079849
Vaccine. 2016 Jun 3;34(26):2926-2933
pubmed: 27038130
Science. 2013 Nov 22;342(6161):976-9
pubmed: 24264991
J Virol. 2015 Oct 14;90(1):332-44
pubmed: 26468547
J Virol. 1968 Aug;2(8):778-86
pubmed: 5701819
Semin Immunol. 2018 Dec;40:83-94
pubmed: 30501873
Clin Microbiol Rev. 2013 Jul;26(3):476-92
pubmed: 23824369
PLoS Pathog. 2011 Nov;7(11):e1002381
pubmed: 22102819
Expert Rev Vaccines. 2012 May;11(5):587-94
pubmed: 22827244
Nat Med. 2014 Feb;20(2):143-51
pubmed: 24412922
J Virol. 1993 Oct;67(10):5721-3
pubmed: 8371337
J Immunol. 2008 Apr 15;180(8):5402-12
pubmed: 18390722
Clin Infect Dis. 2017 Oct 15;65(8):1289-1297
pubmed: 28525597
Curr Opin Virol. 2013 Oct;3(5):521-30
pubmed: 23978327
Annu Rev Immunol. 1994;12:63-84
pubmed: 8011293
Lancet Infect Dis. 2014 Dec;14(12):1196-207
pubmed: 25455987
Clin Infect Dis. 2014 Nov 1;59(9):1246-55
pubmed: 25048848
J Virol. 2008 Jun;82(11):5161-6
pubmed: 18353950
Clin Exp Dermatol. 2002 Oct;27(7):571-7
pubmed: 12464152
PLoS One. 2016 Aug 15;11(8):e0161193
pubmed: 27525409
Nat Rev Drug Discov. 2021 Jan;20(1):39-63
pubmed: 33077936
PLoS Med. 2007 Feb;4(2):e59
pubmed: 17298168
J Gen Virol. 2010 Nov;91(Pt 11):2745-52
pubmed: 20719991
J Immunol. 2011 Jan 15;186(2):1022-31
pubmed: 21169548
Vaccine. 2013 Dec 5;31(50):6030-3
pubmed: 24095882
Sci Rep. 2015 Jul 31;5:12321
pubmed: 26227481
Immunity. 2013 Feb 21;38(2):275-84
pubmed: 23333074
Nat Med. 2013 Oct;19(10):1305-12
pubmed: 24056771
Nat Commun. 2015 May 13;6:6833
pubmed: 25967273
Front Immunol. 2013 May 16;4:114
pubmed: 23720661
Nat Rev Drug Discov. 2020 Apr;19(4):239-252
pubmed: 32060419
Vaccines (Basel). 2020 Jul 06;8(3):
pubmed: 32640619
Lancet Infect Dis. 2012 Jan;12(1):36-44
pubmed: 22032844
N Engl J Med. 1983 Jul 7;309(1):13-7
pubmed: 6602294
J Infect Dis. 1974 Apr;129(4):411-20
pubmed: 4593871
Hum Vaccin Immunother. 2016 Nov;12(11):2881-2901
pubmed: 27455345
Front Cell Infect Microbiol. 2019 Apr 17;9:107
pubmed: 31065546
Am J Epidemiol. 2012 Sep 15;176(6):527-33
pubmed: 22940713
J Infect Dis. 2019 Apr 19;219(10):1525-1535
pubmed: 30551178
PLoS One. 2012;7(10):e48322
pubmed: 23118984
Hum Vaccin Immunother. 2015;11(8):2102-12
pubmed: 26091244
Nat Rev Microbiol. 2015 Jan;13(1):28-41
pubmed: 25417656
J Virol. 2013 Aug;87(16):9290-300
pubmed: 23785204
Hum Vaccin Immunother. 2016;12(1):239-43
pubmed: 26836329
J Infect. 2017 Nov;75(5):381-394
pubmed: 28935236
Dev Biol (Basel). 2003;115:63-73
pubmed: 15088777
Front Immunol. 2018 Jul 09;9:1556
pubmed: 30038619
Cell. 2018 Apr 5;173(2):417-429.e10
pubmed: 29625056
Oncoimmunology. 2015 Jan 07;4(3):e989764
pubmed: 25949902
Vaccines (Basel). 2015 Apr 24;3(2):373-89
pubmed: 26343192
Clin Microbiol Infect. 2019 Oct;25(10):1213-1225
pubmed: 31284031
J Infect Dis. 2019 Apr 8;219(Suppl_1):S5-S13
pubmed: 30715352
J Infect Dis. 2018 Jul 13;218(4):614-623
pubmed: 29912453
mBio. 2016 Apr 19;7(2):e00417-16
pubmed: 27094330
Vaccine. 2007 Jan 8;25(4):612-20
pubmed: 17005299
J Clin Invest. 2008 Oct;118(10):3478-90
pubmed: 18802496
J Virol. 1993 May;67(5):2552-8
pubmed: 7682624
Vaccine. 2015 Jan 15;33(4):500-6
pubmed: 25498210
Curr Trop Med Rep. 2020;7(3):92-97
pubmed: 32837829
Curr Opin Immunol. 2018 Aug;53:51-57
pubmed: 29680576
J Virol. 2014 Feb;88(3):1684-93
pubmed: 24257602
Trans Assoc Am Physicians. 1965;78:323-33
pubmed: 5864978
Eur J Immunol. 1993 Jul;23(7):1719-22
pubmed: 8325342
Nat Immunol. 2017 Mar;18(3):354-363
pubmed: 28114291
Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20748-53
pubmed: 22143798
Expert Rev Vaccines. 2013 Sep;12(9):1085-94
pubmed: 24024871
N Engl J Med. 2001 Mar 22;344(12):889-96
pubmed: 11259722
Hum Vaccin Immunother. 2018 Mar 4;14(3):550-564
pubmed: 29232151
Lancet Infect Dis. 2016 Feb;16(2):209-18
pubmed: 26559482
Nat Rev Immunol. 2009 Mar;9(3):185-94
pubmed: 19240757
Vaccines (Basel). 2018 Mar 26;6(2):
pubmed: 29587436
J Exp Med. 1987 Feb 1;165(2):408-16
pubmed: 3029268
mBio. 2016 Aug 02;7(4):
pubmed: 27486196
Pharmacol Res. 2020 Feb;152:104609
pubmed: 31862477
J Immunol. 1999 Jun 15;162(12):7578-83
pubmed: 10358215
mBio. 2015 Mar 10;6(2):e02556
pubmed: 25759506
Viruses. 2020 Sep 17;12(9):
pubmed: 32957468
Pediatr Infect Dis J. 2012 Apr;31(4):e59-65
pubmed: 22418661
Vaccine. 2017 Apr 11;35(16):1996-2006
pubmed: 28302409
Immunol Rev. 2020 Jul;296(1):132-141
pubmed: 32542739
Int J Health Geogr. 2012 May 17;11:16
pubmed: 22594494
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Cell Immunol. 1999 Nov 25;198(1):69-75
pubmed: 10612653
J Clin Invest. 2011 Jun;121(6):2111-7
pubmed: 21633179
Biomed Res Int. 2015;2015:504831
pubmed: 25815321
J Prev Med Hyg. 2016 Sep;57(3):E115-E120
pubmed: 27980374
Expert Rev Vaccines. 2009 Apr;8(4):499-508
pubmed: 19348565
J Immunol. 2008 Sep 15;181(6):4168-76
pubmed: 18768874
J Neuroimmunol. 2018 Jan 15;314:30-41
pubmed: 29169800

Auteurs

Tanja Becker (T)

Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Hannover, Germany.

Husni Elbahesh (H)

Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Hannover, Germany.

Leslie A Reperant (LA)

Artemis One Health Research Foundation, Delft, The Netherlands.

Guus F Rimmelzwaan (GF)

Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Hannover, Germany.

Albert D M E Osterhaus (ADME)

Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Hannover, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH